Free Trial

Vincerx Pharma (VINC) SEC Filings & 10K Form

Vincerx Pharma logo
$0.05 -0.01 (-21.77%)
As of 07/25/2025 03:05 PM Eastern

Recent Vincerx Pharma SEC Filings

DateFilerForm TypeView
07/16/2025
3:14 PM
Vincerx Pharma (Filer)
Form DEFA14A
07/07/2025
3:23 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2025
3:27 PM
Vincerx Pharma (Filer)
Form DEFA14A
06/18/2025
3:18 PM
Vincerx Pharma (Filer)
Form DEFA14A
05/15/2025
2:13 PM
ARMISTICE CAPITAL, LLC (Filed by)
Vincerx Pharma (Subject)
Form SCHEDULE 13G/A
05/12/2025
3:49 PM
Vincerx Pharma (Filer)
Form DEF 14A
05/04/2025
11:15 PM
Vincerx Pharma (Filer)
Form EFFECT
05/04/2025
11:15 PM
Vincerx Pharma (Filer)
Form EFFECT
05/04/2025
11:15 PM
Vincerx Pharma (Filer)
Form EFFECT
05/01/2025
4:06 PM
Vincerx Pharma (Filer)
Form POS AM
05/01/2025
4:07 PM
Vincerx Pharma (Filer)
Form POS AM
05/01/2025
4:08 PM
Vincerx Pharma (Filer)
Form POS AM
05/01/2025
4:10 PM
Vincerx Pharma (Filer)
Form S-8 POS
05/01/2025
4:11 PM
Vincerx Pharma (Filer)
Form S-8 POS
05/01/2025
4:11 PM
Vincerx Pharma (Filer)
Form S-8 POS
05/01/2025
4:12 PM
Vincerx Pharma (Filer)
Form S-8 POS
05/01/2025
4:13 PM
Vincerx Pharma (Filer)
Form S-8 POS
04/30/2025
3:41 PM
Vincerx Pharma (Filer)
Form PRE 14A
04/17/2025
3:52 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2025
3:03 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
11:15 PM
Vincerx Pharma (Filer)
Form EFFECT
03/31/2025
3:02 PM
Vincerx Pharma (Filer)
Form S-3/A
03/18/2025
8:02 AM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
8:05 AM
Vincerx Pharma (Subject)
Form 425
02/12/2025
7:30 AM
Prosight Management, LP (Filed by)
Vincerx Pharma (Subject)
Form SCHEDULE 13G/A
02/11/2025
6:09 PM
Long Focus Capital Management, LLC (Filed by)
Vincerx Pharma (Subject)
Form SCHEDULE 13G/A
02/06/2025
3:05 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
3:06 PM
Vincerx Pharma (Filer)
Form DEFA14A
01/29/2025
3:05 PM
Vincerx Pharma (Filer)
Form DEFA14A
01/23/2025
3:10 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:13 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:15 PM
Vincerx Pharma (Filer)
Form DEFA14A
01/21/2025
3:31 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
3:29 PM
Vincerx Pharma (Filer)
Form 424B5
01/16/2025
4:11 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:12 PM
Vincerx Pharma (Filer)
Form 424B5
12/27/2024
3:13 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2024
4:05 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
10:57 AM
BANK OF AMERICA CORP /DE/ (Filed by)
Vincerx Pharma (Subject)
Form SC 13G/A
11/13/2024
7:32 AM
Prosight Management, LP (Filed by)
Vincerx Pharma (Subject)
Form SC 13G/A
11/05/2024
8:15 AM
Vincerx Pharma (Filer)
Form PRE 14A
Trump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready? (Ad)

Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that you don't want to take with your retirement savings.

>> Get your FREE copy of the2025 Retirement Protection Guide today <<
09/30/2024
5:57 AM
Vincerx Pharma (Subject)
Form SC TO-I/A
09/10/2024
3:02 PM
Vincerx Pharma (Subject)
Form SC TO-I/A
08/16/2024
3:01 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:11 PM
THOMAS TOM C (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:00 PM
Izumi Raquel E. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:03 PM
Seelenberger Alexander A. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:07 PM
Hamdy Ahmed MD (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:37 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:39 PM
Vincerx Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VINC) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners